Biomea Fusion (BMEA) vs Milestone Pharmaceuticals (MIST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Biomea Fusion (BMEA) has outperformed Milestone Pharmaceuticals (MIST) over the past year, losing 28.5% versus a loss of 63.6%. Over five years, MIST leads with a -87.2% price change compared with -88.7% for BMEA. Biomea Fusion is the larger company by market cap ($95.4 million vs $94.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BMEA | MIST |
|---|---|---|
| Share price | $1.32 | $0.7572 |
| Market cap | $95.44M | $94.27M |
| 1-day change | +5.60% | -0.92% |
| YTD return | +6.45% | -62.51% |
| 1-year return | -28.46% | -63.60% |
| 5-year return | -88.65% | -87.17% |
| EPS (TTM) | $-0.29 | $-0.68 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.24 | $3.06 |
| 52-week low | $0.872 | $0.725 |
| Distance from 52-week high | -40.99% | -75.25% |
| Average volume | 1.47M | 1.39M |
| Shares outstanding | 72.30M | 124.50M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BMEA has outperformed MIST by 35.1 percentage points over the past year.
BMEA vs MIST FAQ
Which is bigger, Biomea Fusion or Milestone Pharmaceuticals?
Biomea Fusion (BMEA) is larger, with a market capitalization of $95.44M compared with $94.27M for Milestone Pharmaceuticals (MIST).
Which stock has performed better over the past year, BMEA or MIST?
BMEA returned -28.46% over the past 12 months, compared with -63.60% for MIST (price return, excluding dividends). Past performance does not predict future results.
Are Biomea Fusion and Milestone Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.